Publication Beamlines Strategic Pillar
호안 세오안 수아레즈; 후디트 아니도 폴구에이라; 로빈 매튜 홀레트; 파트리샤 앤 깁린; 잔느 마그람 et al. (2021). Combination of LIF inhibitors and platinum-based anti-neoplastic agents for use in treating cancer. Patent Number: KR20210022065A.
호안 세오안 수아레즈; 후디트 아니도 폴구에이라; 요한 프란손; 로빈 매튜 할렛; 모니카 파스쿠알 가르시아 et al. (2021). Combination of LIF inhibitor and PD-1 axis inhibitor for use in treating cancer. Patent Number: KR20210021287A.
(2021). Methods for improving response to anti-lif antibody treatment in individuals with cancer. Patent Number: IL279484A.
(2021). Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer. Patent Number: IL279444A.